Gene therapy from Biogen's $800M buyout flops in mid-stage study, dealing blow to new ambitions

Jason Mast. Editor. The #2 candidate from Biogen's $800 million ocular gene therapy buyout has failed in a mid-stage trial, ...
https://www.google.com/url?rct=j&sa=t&url=https://endpts.com/gene-therapy-from-biogens-800m-buyout-flops-in-mid-stage-study-dealing-blow-to-new-ambitions/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHGioJ9B7a6FkHihItrXf-KXZZEEA